Michael Baboudjian

Dr. Michael Baboudjian

Aix-Marseille Université
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
TLThi Khanh LE
Thi Khanh LE
QDQuang Hieu DUONG
Quang Hieu DUONG
VBVirginie Baylot
Virginie Baylot
CFChristelle FARGETTE
Christelle FARGETTE
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
Palma RocchiPalma Rocchi
Palma Rocchi
Prostate cancer (PC) is the second most common cancer in men worldwide. Despite recent advances in diagnosis and treatment, castration-resistant prostate cancer (CRPC) remains a significant medical challenge. Prostate cancer cells can develop mechanisms to resist androgen deprivation therapy, such as AR overexpression, AR mutations, alterations in AR coregulators, increased steroidogenic signaling pathways, outlaw pathways, and bypass pathways. Various treatment options for CRPC exist, including androgen deprivation therapy, chemotherapy, immunotherapy, localized or systemic therapeutic radiation, and PARP inhibitors. However, more research is needed to combat CRPC effectively. Further investigation into the underlying mechanisms of the disease and the development of new therapeutic strategies will be crucial in improving patient outcomes. The present work summarizes the current knowledge regarding the underlying mechanisms that promote CRPC, including both AR-dependent and independent pathways. Additionally, we provide an overview of the currently approved therapeutic options for CRPC, with special emphasis on chemotherapy, radiation therapy, immunotherapy, PARP inhibitors, and potential combination strategies.

4 August 2022 in European Urology Oncology
Verified
Journal Article
Closed access
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
ABAlberto Breda
Alberto Breda
PRPawel Rajwa
Pawel Rajwa
AGAndrea Gallioli
Andrea Gallioli
BGBastien Gondran-Tellier
Bastien Gondran-Tellier
GPGuillaume Ploussard
Guillaume Ploussard

29 July 2019 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
BGBastien Gondran-Tellier
Bastien Gondran-Tellier
RARony Abdallah
Rony Abdallah
PSPierre Clement Sichez
Pierre Clement Sichez
AAAkram Akiki
Akram Akiki
RBRomain Boissier
Romain Boissier

20 December 2022 in European Urology Focus
Verified
Journal Article
Closed access
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
BPBenjamin Pradere
Benjamin Pradere
NMNathalie Martin
Nathalie Martin
BGBastien Gondran-Tellier
Bastien Gondran-Tellier
OAOriol Angerri
Oriol Angerri
ELEric Lechevallier
Eric Lechevallier

21 April 2024 in European Urology
Verified
Journal Article
Closed access
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
HHHashim Hashim
Hashim Hashim
NBNikita Bhatt
Nikita Bhatt
MCMassimiliano Creta
Massimiliano Creta
CNCosimo De Nunzio
Cosimo De Nunzio
JCJean-Nicolas Cornu
Jean-Nicolas Cornu

31 July 2019 in BJU International
Verified
Journal Article
Closed access
PDF file
BGBastien Gondran‐Tellier
Bastien Gondran‐Tellier
RBRomain Boissier
Romain Boissier
Michael BaboudjianMichael Baboudjian
Michael Baboudjian
MRMathieu Rouy
Mathieu Rouy
SGSarah Gaillet
Sarah Gaillet
GKGilles Karsenty
Gilles Karsenty